25.05.2017
- Novartis has signed a Memorandum of Understanding (MoU) with Pakistan’s Ministry of National Health Services, Regulations and Coordination to increase access to treatment for poor...
15.05.2017
- Swiss pharma company Novartis has exercised an option that gives it global development and commercialization rights to a drug being developed by US biotech Conatus Pharmaceuticals...
08.05.2017
- Major drug makers Allergan and Novartis are collaborating to test a new combination therapy for non-alcoholic steatohepatitis (NASH), a progressive form of fatty liver disease said...
27.04.2017
- Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...
26.04.2017
- The chemical industry is the most important supplier of the pharmaceutical industry, but it can´t keep pace with the economic strength and R&D intensity of pharma. This underlines...
12.04.2017
- Swiss pharmaceutical major Novartis has chosen to exercise an option to in-license an experimental eye drug from US biopharma Lubris. The drug, ECF843, is a recombinant human...
22.03.2017
- The US Food and Drug Administration (FDA) has approved Novartis’ new drug Kisqali (ribociclib) as an initial treatment for postmenopausal women with a type of metastatic breast...
27.02.2017
- The US Food and Drug Administration (FDA) has accepted Swiss pharmaceutical major Novartis’ supplemental New Drug Application (sNDA) for filing and granted priority review for the...
